Objectives are to build a portfolio of investors, partners, and supply chain production operations throughout the United States that are at various stages of legislative development and leverage our core competencies and strengths. Each project is centered around cultivation and cannabinoid-based drug development programs targeting critical ailments. Each large-scale property and drug development project is designed to generate hundreds of jobs in the construction, farming, medical, retail, and education industries.
Details of the CBIS & CBCA arrangement are pending. Mr. Dabney is working to make the best deal structure for all shareholders involved, including a CBIS shareholder stake in CBCA. Working together is in the best interests of both CBCA and CBIS as this type of relationship makes things much simpler and consequently an exercise of financial strength and growth for both Companies.
For the full press release go to Financial Content
Read More